BridgeMD
New treatment option for Persistent Corneal Epithelial Defect
Official title Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects
ClinicalTrials.gov ID: NCT07561398
What this study is testing
What is Topical insulin eye drops?
Topical insulin eye drops is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for persistent corneal epithelial defect.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- After an initial period of standard treatment, they received further care aimed at helping the surface of the eye heal. Clear instructions were given on how to use and store the treatment properly.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Corneal epithelial defects for more than 2 weeks no improvement using standard treatment
You likely can't join if
- Systemic conditions e.g. uncontrolled Diabetes, autoimmune disorders
- Recent eye surgery within last 3 months
- Hereditary corneal dystrophies
- Active eye infections
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.